• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性意识障碍患者肠道微生物组和脂代谢的改变。

Altered Intestinal Microbiomes and Lipid Metabolism in Patients With Prolonged Disorders of Consciousness.

机构信息

Department of Neurology, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.

Department of Neurology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Zhejiang, China.

出版信息

Front Immunol. 2022 Jul 13;13:781148. doi: 10.3389/fimmu.2022.781148. eCollection 2022.

DOI:10.3389/fimmu.2022.781148
PMID:35911767
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9326017/
Abstract

The intestinal microbiota regulate the brain function of the host through the production of a myriad of metabolites and are associated with various neurological diseases. Understanding the intestinal microbiome of patients with prolonged disorders of consciousness (DoC) is important for the evaluation and treatment of the disease. To investigate the differences in the intestinal microbiome and short-chain fatty acids (SCFAs) among patients in a vegetative state (VS), a minimally conscious state (MCS), and emerged from MCS (EMCS), as well as the influence of antibiotics on these patients, 16S ribosomal RNA (16S rRNA) sequencing and targeted lipidomics were performed on fecal samples from patients; in addition, analysis of the electroencephalogram (EEG) signals was performed to evaluate the brain function of these patients. The results showed that the intestinal microbiome of the three groups differed greatly, and some microbial communities showed a reduced production of SCFAs in VS patients compared to the other two groups. Moreover, reduced microbial communities and five major SCFAs, along with attenuated brain functional connectivity, were observed in MCS patients who were treated with antibiotics compared to those who did not receive antibiotic treatment, but not in the other pairwise comparisons. Finally, three genus-level microbiota-, and -were considered as potential biomarkers to distinguish MCS from VS patients, with high accuracy both in the discovery and validation cohorts. Together, our findings improved the understanding of patients with prolonged DoC from the intestinal microbiome perspective and provided a new reference for the exploration of therapeutic targets.

摘要

肠道微生物群通过产生大量代谢物来调节宿主的大脑功能,并且与各种神经疾病有关。了解持续性意识障碍(DOC)患者的肠道微生物群对于评估和治疗该疾病非常重要。为了研究植物状态(VS)、最小意识状态(MCS)和从 MCS 中苏醒的患者(EMCS)之间的肠道微生物群和短链脂肪酸(SCFA)的差异,以及抗生素对这些患者的影响,对患者粪便样本进行了 16S 核糖体 RNA(16S rRNA)测序和靶向脂质组学分析;此外,还对脑电图(EEG)信号进行了分析,以评估这些患者的大脑功能。结果表明,三组患者的肠道微生物群差异很大,与其他两组相比,一些微生物群落中 SCFA 的产生减少。此外,与未接受抗生素治疗的患者相比,接受抗生素治疗的 MCS 患者的微生物群落减少,并且五种主要的 SCFAs 减少,大脑功能连接减弱,但在其他两两比较中则没有观察到这种情况。最后,三个属水平的微生物群和被认为是区分 MCS 和 VS 患者的潜在生物标志物,在发现和验证队列中都具有较高的准确性。总之,我们的研究结果从肠道微生物群的角度提高了对持续性意识障碍患者的理解,并为探索治疗靶点提供了新的参考。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe95/9326017/76165ef0e0f0/fimmu-13-781148-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe95/9326017/37f9cdf3e066/fimmu-13-781148-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe95/9326017/c4e4c44df76f/fimmu-13-781148-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe95/9326017/e46213501db6/fimmu-13-781148-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe95/9326017/8d1eb3003cfb/fimmu-13-781148-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe95/9326017/96dca8e47b9f/fimmu-13-781148-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe95/9326017/76165ef0e0f0/fimmu-13-781148-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe95/9326017/37f9cdf3e066/fimmu-13-781148-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe95/9326017/c4e4c44df76f/fimmu-13-781148-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe95/9326017/e46213501db6/fimmu-13-781148-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe95/9326017/8d1eb3003cfb/fimmu-13-781148-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe95/9326017/96dca8e47b9f/fimmu-13-781148-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe95/9326017/76165ef0e0f0/fimmu-13-781148-g006.jpg

相似文献

1
Altered Intestinal Microbiomes and Lipid Metabolism in Patients With Prolonged Disorders of Consciousness.慢性意识障碍患者肠道微生物组和脂代谢的改变。
Front Immunol. 2022 Jul 13;13:781148. doi: 10.3389/fimmu.2022.781148. eCollection 2022.
2
Normal Light-Dark and Short-Light Cycles Regulate Intestinal Inflammation, Circulating Short-chain Fatty Acids and Gut Microbiota in Gene Knockout Mice.正常的明暗和短光周期调节基因敲除小鼠的肠道炎症、循环短链脂肪酸和肠道微生物群。
Front Immunol. 2022 Mar 18;13:848248. doi: 10.3389/fimmu.2022.848248. eCollection 2022.
3
Fecal metabonomics combined with 16S rRNA gene sequencing to analyze the changes of gut microbiota in rats with kidney-yang deficiency syndrome and the intervention effect of You-gui pill.基于粪便代谢组学联合 16S rRNA 基因测序分析肾阳虚证大鼠肠道菌群变化及右归丸的干预作用
J Ethnopharmacol. 2019 Nov 15;244:112139. doi: 10.1016/j.jep.2019.112139. Epub 2019 Aug 8.
4
Immunomodulatory potential of gut microbiome-derived short-chain fatty acids (SCFAs).肠道微生物群衍生的短链脂肪酸(SCFAs)的免疫调节潜力。
Acta Biochim Pol. 2019 Mar 4;66(1):1-12. doi: 10.18388/abp.2018_2648.
5
Analysis of Gut Microbiome and Metabolite Characteristics in Patients with Slow Transit Constipation.慢传输型便秘患者的肠道微生物组和代谢物特征分析。
Dig Dis Sci. 2021 Sep;66(9):3026-3035. doi: 10.1007/s10620-020-06500-2. Epub 2020 Aug 7.
6
Dysbiosis of Gut Microbiota and Short-Chain Fatty Acids in Acute Ischemic Stroke and the Subsequent Risk for Poor Functional Outcomes.肠道微生物失调与短链脂肪酸在急性缺血性脑卒中及其不良功能结局风险中的作用。
JPEN J Parenter Enteral Nutr. 2021 Mar;45(3):518-529. doi: 10.1002/jpen.1861. Epub 2020 May 30.
7
The relationship between gut microbiota and short chain fatty acids in the renal calcium oxalate stones disease.肠道微生物群与肾脏草酸钙结石病中短链脂肪酸的关系。
FASEB J. 2020 Aug;34(8):11200-11214. doi: 10.1096/fj.202000786R. Epub 2020 Jul 9.
8
Dysbiosis of Gut Microbiota and Short-Chain Fatty Acids in Encephalitis: A Chinese Pilot Study.肠道微生物群失调与脑炎中的短链脂肪酸:一项中国初步研究。
Front Immunol. 2020 Aug 20;11:1994. doi: 10.3389/fimmu.2020.01994. eCollection 2020.
9
Metabolic Abnormalities in Patients with Chronic Disorders of Consciousness.慢性意识障碍患者的代谢异常
Aging Dis. 2021 Apr 1;12(2):386-403. doi: 10.14336/AD.2020.0812. eCollection 2021 Apr.
10
A High Salt Diet Modulates the Gut Microbiota and Short Chain Fatty Acids Production in a Salt-Sensitive Hypertension Rat Model.高盐饮食可调节盐敏感高血压大鼠模型的肠道微生物群和短链脂肪酸产生。
Nutrients. 2018 Aug 23;10(9):1154. doi: 10.3390/nu10091154.

引用本文的文献

1
Lung and gut microbiota profiling in intensive care unit patients: a prospective pilot study.重症监护病房患者的肺部和肠道微生物群分析:一项前瞻性试点研究。
BMC Infect Dis. 2025 Apr 5;25(1):468. doi: 10.1186/s12879-025-10825-6.
2
Gut-brain axis and neuroplasticity in health and disease: a systematic review.健康与疾病中的肠-脑轴及神经可塑性:一项系统综述
Radiol Med. 2025 Mar;130(3):327-358. doi: 10.1007/s11547-024-01938-0. Epub 2024 Dec 24.
3
Efficacy of melatonin for prolonged disorders of consciousness: a double-blind, randomized clinical trial.

本文引用的文献

1
Tibetan Pig-Derived Probiotic SLZX20-1 Improved Intestinal Function Producing Enzymes and Regulating Intestinal Microflora.藏猪源益生菌SLZX20-1通过产生酶和调节肠道微生物群改善肠道功能。
Front Nutr. 2022 Mar 29;9:846991. doi: 10.3389/fnut.2022.846991. eCollection 2022.
2
Short-Chain Fatty Acids, Maternal Microbiota and Metabolism in Pregnancy.短链脂肪酸、孕产妇微生物组与妊娠代谢
Nutrients. 2021 Apr 9;13(4):1244. doi: 10.3390/nu13041244.
3
Metabolic Abnormalities in Patients with Chronic Disorders of Consciousness.慢性意识障碍患者的代谢异常
褪黑素对长期意识障碍的疗效:一项双盲随机临床试验。
BMC Med. 2024 Dec 3;22(1):576. doi: 10.1186/s12916-024-03793-2.
4
Subchronic toxic effects of bisphenol A on the gut-liver-hormone axis in rats via intestinal flora and metabolism.双酚 A 通过肠道菌群及其代谢物对大鼠肠-肝-激素轴的亚慢性毒性作用。
Front Endocrinol (Lausanne). 2024 Aug 29;15:1415216. doi: 10.3389/fendo.2024.1415216. eCollection 2024.
5
Alterations in metabolome and lipidome in patients with in-stent restenosis.支架内再狭窄患者代谢组和脂质组的改变。
CNS Neurosci Ther. 2024 Jul;30(7):e14832. doi: 10.1111/cns.14832.
6
Chewing the fat: How lipidomics is changing our understanding of human health and disease in 2022.闲聊:脂质组学如何在2022年改变我们对人类健康与疾病的理解。
Anal Sci Adv. 2023 May 10;4(3-4):104-131. doi: 10.1002/ansa.202300009. eCollection 2023 May.
Aging Dis. 2021 Apr 1;12(2):386-403. doi: 10.14336/AD.2020.0812. eCollection 2021 Apr.
4
Gut-Brain-Microbiota Axis: Antibiotics and Functional Gastrointestinal Disorders.肠-脑-微生物群轴:抗生素与功能性胃肠病。
Nutrients. 2021 Jan 27;13(2):389. doi: 10.3390/nu13020389.
5
The gut microbiota-brain axis in behaviour and brain disorders.肠道微生物群-脑轴与行为和脑部疾病。
Nat Rev Microbiol. 2021 Apr;19(4):241-255. doi: 10.1038/s41579-020-00460-0. Epub 2020 Oct 22.
6
A multi-domain prognostic model of disorder of consciousness using resting-state fMRI and laboratory parameters.使用静息态 fMRI 和实验室参数的意识障碍多领域预后模型。
Brain Imaging Behav. 2021 Aug;15(4):1966-1976. doi: 10.1007/s11682-020-00390-8. Epub 2020 Oct 11.
7
Gut microbial metabolites as multi-kingdom intermediates.肠道微生物代谢物作为多王国中间产物。
Nat Rev Microbiol. 2021 Feb;19(2):77-94. doi: 10.1038/s41579-020-0438-4. Epub 2020 Sep 23.
8
Gut microbiota interacts with intrinsic brain activity of patients with amnestic mild cognitive impairment.肠道微生物群与遗忘型轻度认知障碍患者的内在大脑活动相互作用。
CNS Neurosci Ther. 2021 Feb;27(2):163-173. doi: 10.1111/cns.13451. Epub 2020 Sep 15.
9
Microbial Diversity and Community Structures Among Those With Moderate to Severe TBI: A United States-Veteran Microbiome Project Study.中度至重度创伤性脑损伤患者的微生物多样性和群落结构:美国退伍军人微生物组计划研究。
J Head Trauma Rehabil. 2020 Sep/Oct;35(5):332-341. doi: 10.1097/HTR.0000000000000615.
10
Sliding Scoring of the Glasgow Outcome Scale-Extended as Primary Outcome in Traumatic Brain Injury Trials.滑动评分的格拉斯哥结局量表-扩展在创伤性脑损伤试验中的主要结局。
J Neurotrauma. 2020 Dec 15;37(24):2674-2679. doi: 10.1089/neu.2019.6969. Epub 2020 Aug 26.